Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments

By Dietrich G.   Viret J.-F.   Hess J.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 667-670

Elsevier

Access to resources Recommend Favorite

Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns

By Nahori M.-A.   Lagranderie  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1484-1495

Elsevier

Access to resources Recommend Favorite

Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen

By Kawahara M.   Matsuo K.   Nakasone T.   Hiroi T.   Kiyono H.   Matsumoto S.   Yamada T.   Yamamoto N.   Honda M.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 158-166

Elsevier

Access to resources Recommend Favorite

Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced Th2 responses

By Major T.   Wohlleben G.   Reibetanz B.   Erb K.J.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1532-1540

Elsevier

Access to resources Recommend Favorite

UV-Induced Inactivation Rates for Airborne Mycobacterium bovis BCG

By Peccia Jordan   Hernandez Mark  

Journal of Occupational and Environmental Hygiene, Vol. 1, Iss. 7, 2004-07 ,pp. : 430-435

Taylor & Francis Ltd

Access to resources Recommend Favorite